Trial Profile

INFORM-3

Planning
Phase of Trial: Phase II

Latest Information Update: 06 Jan 2011

At a glance

  • Drugs Danoprevir; Mericitabine; Peginterferon alfa-2a; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms INFORM-3; INFORM-SVR
  • Sponsors Roche
  • Most Recent Events

    • 06 Jan 2011 Trial expected to be initiated in the first quarter of 2011, according to a Pharmasset media release.
    • 06 Jan 2011 Planned initiation date changed to 1 Jan 2011.
    • 23 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top